Reviva Pharmaceuticals Holdings Inc. (RVPH) — Strategic Asset Allocation Index
Reviva Pharmaceuticals Holdings Inc. (RVPH) has a Strategic Asset Allocation Index of 0.0% as of September 2020. Strategic assets (PP&E of $107.00 plus long-term investments of $-) total $107.00, measured against net assets of $30.10 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Reviva Pharmaceuticals Holdings Inc.'s balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Reviva Pharmaceuticals Holdings Inc. Strategic Asset Allocation Index (2018–2018)
This chart shows how Reviva Pharmaceuticals Holdings Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2018 to 2018. As of September 2020, the index stands at 0.0%, representing strategic assets of $107.00 against net assets of $30.10 Million USD. For live market cap and overall valuation, see Reviva Pharmaceuticals Holdings Inc. (RVPH) market capitalisation.
Annual Strategic Asset Allocation Index for Reviva Pharmaceuticals Holdings Inc. (2018–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Reviva Pharmaceuticals Holdings Inc. from 2018 to 2018, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Reviva Pharmaceuticals Holdings Inc. book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 0.0% | $1.24K | $1.24K | $- | $59.16 Million | — |